| Literature DB >> 25210516 |
O S Adeyemi1, A F Sulaiman2, O M Iniaghe3.
Abstract
Current chemotherapies against trypanosomiasis are beset with diverse challenges, a situation which underscores the numerous research efforts aimed at finding newer and effective treatments. Arginine kinase of trypanosome has been validated as target for drug development against trypanosomiasis. The present study investigated the interaction between a recombinant form of the arginine kinase (rTbAK) of trypanosome and gallotannin. The interaction between gallotannin and recombinant arginine kinase of Trypanosoma brucei caused significant decrease of enzyme activity. Kinetic analysis revealed the interaction to be of noncompetitive inhibition. Further thermodynamic analysis showed that the interaction between gallotannin and the recombinant arginine kinase was nonspontaneous and involved hydrophobic forces. The K sv values and the FRET analysis suggest that static quenching of fluorescence intensity by gallotannin was static. Data revealed inhibitory interactions between gallotannin and rTbAK of trypanosome. Although the mechanism of inhibition is not clear yet, molecular docking studies are ongoing to clearly define the inhibitory interactions between the gallotannin and rTbAK. The knowledge of such binding properties would enrich development of selective inhibitors for the arginine kinase of Trypanosoma brucei.Entities:
Year: 2014 PMID: 25210516 PMCID: PMC4158470 DOI: 10.1155/2014/675905
Source DB: PubMed Journal: J Biophys ISSN: 1687-8000
Figure 1Hanes-Woolf plots for the interaction of gallotannin with a recombinant arginine kinase of Trypanosoma brucei in the presence of different concentrations of (a) L-arginine and (b) ATP, respectively.
Figure 2Relative activities of recombinant arginine kinase of Trypanosoma brucei in the presence of gallotannin at different concentrations of (a) L-arginine and (b) ATP.
Figure 3Stern-Volmer plots showing fluorescence quenching of the recombinant arginine kinase of Trypanosoma brucei in the presence of gallotannin at different temperatures. (a) Quenching of arginine kinase of Trypanosoma brucei by gallotannin and (b) Quenching of arginine kinase of Trypanosoma brucei by gallotannin.
Stern-Volmer constant (K sv) estimated for the interaction between recombinant arginine kinase of Trypanosoma brucei (rTbAK) and gallotannin.
| Inhibitors |
|
|
|
|---|---|---|---|
| Gallotannin | 298 | 11.10 × 104 | 0.9246 |
| 303 | 10.00 × 104 | 0.8828 |
aThe correlation coefficient.
Thermodynamic parameters, binding constant (K), and number of binding sites (n) estimated for the interaction between recombinant arginine kinase of Trypanosoma brucei (rTbAK) and gallotannin.
| Inhibitors |
|
|
|
| Δ | Δ | Δ |
|---|---|---|---|---|---|---|---|
| Gallotannin | 298 | 3.7 × 104 | 1.2176 | 0.9494 | −8.40 | 8.12 | 55.60 |
| 303 | 3.5 × 104 | 1.3381 | 0.9713 | 8.45 | 55.60 |
aThe correlation coefficient.
Figure 4Spectral overlap between the fluorescence of arginine kinase of Trypanosoma brucei and the absorbance of gallotannin. (a) Fluorescence emission spectrum of rTbAK and (b) UV spectrum of gallotannin.
Estimates of the distance (r) for the interaction between arginine kinase of Trypanosoma brucei (TbAK) and gallotannin.
| Inhibitors | Spectral overlap ( |
|
|
|---|---|---|---|
| Gallotannin | 4.33 × 10−14 | 2.13 | 2.28 |